Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,6S,9S,15S,18S,21S,24S,27S)-24-(2-amino-2-oxoethyl)-21-(3-amino-3-oxopropyl)-18,27-bis(4-aminobutyl)-1-((S)-1-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,35S,38S)-17,35-bis((1H-indol-3-yl)methyl)-38-amino-8,20-bis(4-aminobutyl)-2-sec-butyl-29-((R)-1-hydroxyethyl)-11,26-diisobutyl-5,14,23-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-39-phenyl-3,6,9,12,15,18,21,24,27,30,33,36-dodecaazanonatriacontane)pyrrolidin-2-yl)-3,6-dimethyl-9,15-bis(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,25-nonaoxo-2,5,8,11,14,17,20,23,26-nonaazaoctacosan-28-oic acid
ID: ALA5175912
PubChem CID: 168274550
Max Phase: Preclinical
Molecular Formula: C120H189N31O27S2
Molecular Weight: 2562.16
Associated Items: